Article
Distinct genomic aberrations associated with ERG rearranged prostate cancer
20 Jan 2009
Abstract excerpt
Emerging molecular and clinical data suggest that ETS fusion prostate cancer represents a distinct molecular subclass, driven most commonly by a hormonally regulated promoter and characterized by an aggressive natural history. The study of the genomic landscape of prostate cancer in the light of ETS fusion events is required to understand the foundation of this molecularly and clinically distinct subtype. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
